Gastroenterology was consulted and recommended further evaluation with tumor markers, including alpha-fetoprotein (AFP) and chromogranin A, as well as magnetic resonance imaging (MRI) of the abdomen and magnetic resonance cholangiopancreatography (MRCP). This evidence concerns the gene AFP and neoplasm.